Biochemistry

Alain Berinstain Joins CSS as Chief Strategy Officer

Retrieved on: 
Thursday, February 15, 2024
White House, Federal Government, Public Policy, Government, Aerospace, Manufacturing, Other Science, Research, Science, Doctor of Philosophy, Multimedia, IMEWG, Micro-g environment, Growth, International Space University, Alain, Moon Express, Physical organic chemistry, Biochemistry, History, Master, Mir, Space Shuttle, International Space Station, CSO, CSS, Management

CSS Inc, www.css-inc.com , an employee-owned, science-based solutions company serving both government and commercial customers, announces today the appointment of Dr. Alain Berinstain as its Chief Strategy Officer (CSO), effective February 12, 2024.

Key Points: 
  • CSS Inc, www.css-inc.com , an employee-owned, science-based solutions company serving both government and commercial customers, announces today the appointment of Dr. Alain Berinstain as its Chief Strategy Officer (CSO), effective February 12, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240215083518/en/
    Berinstain joins the executive team at CSS, reporting to the CEO and co-founder, Dennis Lauchner.
  • When making the announcement, Lauchner said, “Alain is a veteran of the space industry with experience in both the public and private sectors.
  • I am so fortunate to be able to leverage CSS’ 35 years of credibility and capabilities to combine them with my experience and network.

Mikra Reports Further Clinical Research that Validates Category-Defining Formulation of CELLF Cellular Health Supplement

Retrieved on: 
Thursday, February 15, 2024
Randomized controlled trial, Inflammation, Quality of life, Ageing, PQQ, Life, University, Coenzyme Q10, Attention, Oxidative stress, Mikra, Science, Human, Biochemistry, Dietary supplement

In younger adults (aged 20-40 years), PQQ improved cognitive function (cognitive flexibility, processing speed, and execution speed) after 8 weeks...

Key Points: 
  • In younger adults (aged 20-40 years), PQQ improved cognitive function (cognitive flexibility, processing speed, and execution speed) after 8 weeks...
  • Aimed at increasing glutathione and related defenses to improve health status and counteract aging processes in humans.
  • CELLF is a clinically validated formula proven to boost energy and focus on a cellular level, while protecting against the negative effects of oxidative stress.
  • Meticulously researched, the precision-engineered formula is designed to add healthy, energetic years to your life, so you can feel better, longer.

SSP International Announces Doubled Capacity in its Summer Science Program, Expanded Partnerships with U.S. Colleges and Increased Financial Aid

Retrieved on: 
Monday, February 12, 2024
SSP, Chapel, Indiana University, Education, Georgetown University, Southeastern Oklahoma State University, University of Colorado Boulder, Growth, Summer Science Program, Purdue University, New Mexico State University, State university system, Immersion, Face, University, Indiana University Bloomington, Genomics, Science, University of North Carolina, Biochemistry, Student, Management

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- SSP International (SSP), a nonprofit offering advanced science immersion experiences to high school students through its Summer Science Program, today announced that this summer it will double the number of placements available to nearly 400 through new partnerships with Georgia College & State University, Georgetown University and Southeastern Oklahoma State University. These new partnerships will bring the total number of programs to 12 this summer, including five astrophysics programs, three biochemistry programs, three genomics programs and a first-of-its-kind synthetic chemistry program. To reach more deserving participants and increase access to high-quality science education for students historically underrepresented in STEM, the nonprofit will also offer $3,000 stipends to qualified participants who would otherwise have to work in the summer and, in turn, miss out on critical enrichment opportunities.  

Key Points: 
  • "Now operating as SSP International, we are excited to welcome the next generation of students interested in STEM to our Summer Science Program," said Frank Steslow, CEO.
  • "This year, we're especially focused on reaching and engaging individuals who would otherwise not have access to the Summer Science Program experience.
  • Summer Science Program provides programs in astrophysics, biochemistry and genomics taught through rigorous, collaborative research projects on college campuses.
  • If you are interested in applying for its 2024 Summer Science Program, you can visit this link for steps on how to apply: summerscience.org/admissions/how-to-apply .

Pioneering Technique Reveals New Layer of Human Gene Regulation

Retrieved on: 
Friday, February 9, 2024
Human, NYU Langone Health, RNA, Chromatin, Tick, Cell division, Cancer, Howard Hughes Medical Institute, IIS, DNA repair, Genetic code, Bangladesh Technical Education Board, Protein, NYU, RNA polymerase II, Multimedia, DNA, Genome, Biochemistry, Gene expression, Pharmacology, Gene, Bacteria, National Institutes of Health, Ageing, Doctor of Philosophy, Disease, Vaccine

Now a new study led by Nudler's team at NYU Langone Health reveals that their new technique, Long Range Cleavage sequencing (LORAX-seq), can directly detect where backtracking events begin and end.

Key Points: 
  • Now a new study led by Nudler's team at NYU Langone Health reveals that their new technique, Long Range Cleavage sequencing (LORAX-seq), can directly detect where backtracking events begin and end.
  • The results also suggest that persistent backtracking occurs frequently throughout genomes, happens more often near certain gene types, and has functions well beyond DNA repair.
  • "If further work expands our findings to different developmental programs and pathological conditions, backtracking may be akin to epigenetics, the discovery of which revealed a surprising new layer of gene regulation without changing the DNA code."
  • Locked, backtracked complexes are less likely to be rescued by TFIIS-driven cleavage, and more likely to delay transcription of the gene involved.

The Inner Circle Acknowledges, David A. Kisselman acknowledged as a Top Pinnacle Professional

Retrieved on: 
Thursday, February 8, 2024
Chemical engineering, Growth, Mathematics, University, Inner circle, Metropolitan, Petrophysics, Geology, Biochemistry, Jewellery, Civil engineering

FRUITA, Colo., Feb. 8, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, David A. Kisselman is acknowledged as a Top Pinnacle Professional for his contributions as a Renowned Geologist and Entrepreneur.

Key Points: 
  • FRUITA, Colo., Feb. 8, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, David A. Kisselman is acknowledged as a Top Pinnacle Professional for his contributions as a Renowned Geologist and Entrepreneur.
  • In 2019, he ventured into the world of art, creating exquisite jewelry and sculptures using rock specimens collected from diverse locations around the globe.
  • This pioneering endeavor has given rise to a unique art genre that celebrates the intrinsic beauty of these rocks.
  • Mr. Kisselman is affiliated with the American Association of Professional Geologists, a testament to his commitment to the field of geology.

Vilcek Foundation Awards $500,000 in Prizes to Immigrant Scientists and Designers

Retrieved on: 
Tuesday, February 6, 2024
Vilcek Foundation, Research institute, Bacteria, MD, Biochemistry, National academy, Chronic liver disease, Anatomy, Organization, Humanities, Bangladesh Technical Education Board, History, American Academy, Hepatology, Biomedical sciences, IRS, CRISPR, Medicine, University, Student, Foundation (nonprofit), Pratt Institute, Human, Howard Hughes Medical Institute, Work, Organoid, Brain, Doctor of Philosophy, Rockefeller University, Cancer, Art, Research, Cell, Stem cell, Wheelchair, Pharmaceutical industry

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The Vilcek Foundation announces the recipients of the 2024 Vilcek Foundation Prizes. Comprising a total of $500,000 in awards, the prizes align with the foundation's mission and vision: To celebrate immigrant professionals in biomedical science and in the arts and humanities, and to recognize immigrant professionals' contributions to intellectual and cultural life in the United States.

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- The Vilcek Foundation announces the recipients of the 2024 Vilcek Foundation Prizes .
  • Vilcek Foundation awards $500,000 in prizes to immigrant professionals in Biomedical Science and Design.
  • In 2024, four prizes are awarded each in Biomedical Science and in Design: one $100,000 Vilcek Prize, and three $50,000 Vilcek Prizes for Creative Promise.
  • "The United States' leadership in biomedical science and research is in no small part due to the contributions of immigrant scientists," says Jan Vilcek, Chairman and CEO of the Vilcek Foundation.

Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Weizmann Institute of Science, Science, Research, Orange, Government, Therapy, Mentorship, Patient, University, Faculty, Biotechnology, Drug discovery, Chemistry, Investment, Biochemistry, Drug development, Biology, AUC, Student, OGB, Technology transfer, Pharmaceutical industry

Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance).

Key Points: 
  • Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance).
  • Through its collaboration with Bina, Orange Grove will guide and mentor cutting-edge early-stage research taking place across the Weizmann Institute of Science.
  • As part of the collaboration, Orange Grove Bio and Bina will scout for translation of scientific discoveries made by researchers across the Weizmann Institute of Science.
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.

AVROBIO and Tectonic Therapeutic Announce Merger

Retrieved on: 
Tuesday, January 30, 2024
Genetics, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Other Science, Science, Pulmonary hypertension, Hereditary hemorrhagic telangiectasia, Heart failure, Venture, Mergers and acquisitions, Patient, HHT, GPCR, Drug discovery, Concept, Biochemistry, Polaris Partners, Anemia, Harvard Medical School, Biophysics, Drug development, Disease, Bleeding, Fibrosis, Farallon Capital, Biology, G protein-coupled receptor, AVRO

AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc. (“Tectonic”), a privately-held biotechnology company developing GPCR (G-protein coupled receptor)-targeted therapeutic proteins, co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School, today announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction (the “Merger”).

Key Points: 
  • AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc. (“Tectonic”), a privately-held biotechnology company developing GPCR (G-protein coupled receptor)-targeted therapeutic proteins, co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School, today announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction (the “Merger”).
  • Under the terms of the agreement, AVROBIO will acquire 100% of the outstanding equity interests of Tectonic.
  • The private placement is expected to close in conjunction with the Merger in the second quarter of 2024.
  • “We are delighted to merge with AVROBIO at this important time for Tectonic.

Top 40 High School Scientists in Prestigious Regeneron Science Talent Search to Compete for $1.8 Million in Awards

Retrieved on: 
Wednesday, January 24, 2024
Entrepreneurship, Student, Neuroscience, Regeneron Pharmaceuticals, Biochemistry, Materials science, Physics, Research, Environmental science, Mathematics, Animal, Nobel Prize, Social, Knowledge, Chemistry, School, Society, Molecular biology, Medicine, Anxiety, Botany, DSM-IV codes, Creativity, College of Engineering (KNUST), Computational biology, Engineering, Society for Science, Science News, Pharmaceutical industry

TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in this year’s Regeneron Science Talent Search , the nation’s oldest and most prestigious science and math competition for high school seniors.

Key Points: 
  • TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today announced the top 40 finalists in this year’s Regeneron Science Talent Search , the nation’s oldest and most prestigious science and math competition for high school seniors.
  • "We applaud this dynamic group of Regeneron Science Talent Search finalists on their impressive achievement,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News.
  • The top 10 Regeneron Science Talent Search 2024 winners will be announced during an awards ceremony on March 12, streamed live from Washington D.C.
  • In total, more than $3 million in awards will be distributed throughout the Regeneron Science Talent Search.

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

Retrieved on: 
Monday, January 22, 2024
University, Biochemistry, Osteoarthritis, SIGA Technologies, Business administration, Pfizer, Infection, Inflammation, Drug development, TPOXX, Smallpox, Pain, Doctor of Philosophy, Pharmaceutical industry

SIGA’s current CEO, Dr. Phil Gomez, will retire from SIGA on January 26, 2024.

Key Points: 
  • SIGA’s current CEO, Dr. Phil Gomez, will retire from SIGA on January 26, 2024.
  • Additionally, she will represent SIGA in engagements with government partners in the U.S. and internationally, playing a pivotal role in securing new contracts and partnerships.
  • Prior to Xalud, Dr. Nguyen served as executive vice president of biopharma at PPD Inc., a leading global clinical research organization providing integrated drug development services.
  • She earned a Ph.D. in biochemistry and molecular genetics at the University of Virginia, as well as an M.B.A. from Darden Graduate School of Business Administration.